Added to YB: 2023-10-05
Pitch date: 2023-10-05
OCUL [bullish]
Ocular Therapeutix, Inc.
+148.48%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
Market Cap
$1.6B
Pitch Price
$2.97
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.52
P/E
-5.13
EV/Sales
20.61
Sector
Pharmaceuticals
Category
N/A
Show full summary:
OCULAR THERAPEUTIX INC OCUL
A summary for this pitch has not been created yet.
Read full article (0 min)